Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
Subscribe To Our Newsletter & Stay Updated